NCT03680196View on ClinicalTrials.gov

The Effect of Botulinum Toxin Injection at Hip Adductor Muscles in Patients With Spastic Cerebral Palsy, Pilot Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

September 1, 2020

Study Completion Date

August 30, 2021

Conditions
Cerebral Palsy
Interventions
DRUG

medication Botulinum A injection.

In cerebral palsy patients, Botulinum toxin within the allowable dose of 16 U / kg per body weight will injected into both adductor longus, adductor magnus muscle at 3 U / kg, adductor brevis, and gracilis muscle at a dose of 1 U / kg.

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Ju Seok Ryu

OTHER

NCT03680196 - The Effect of Botulinum Toxin Injection at Hip Adductor Muscles in Patients With Spastic Cerebral Palsy, Pilot Study | Biotech Hunter | Biotech Hunter